US FDA approves Omeros' drug to treat dangerous transplant complication

By Padmanabhan Ananthan and Puyaan Singh Dec 24 (Reuters) - The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and children two years and older, marking the first treatment to be greenlit for the condition, the company said on Wednesday. Omeros shares rose nearly 70% in morning trading. The drug, branded Yartemlea, is used to treat